Creative Proteomics Logo
DMPK Bioanalysis Platform ISO 17025

DMPK bioanalytical support for complex molecules and matrices.

Integrated LC-MS/MS-based workflows for discovery and preclinical research.

Our platform brings together quantification, metabolism-related studies, stability assessment, and matrix-aware method strategies to support projects that require both scientific depth and flexible execution.

Explore Services Discuss Your Project
LC-MS/MS-driven quantitative workflows
No clinical, diagnostic, or patient-facing claims

Targeted assay precision

Program-ready quantification assays for plasma, serum, tissues, cell lysates, and metabolite panels.

Complexity-aware design

Built to speak clearly about recovery, matrix effect, degradation risk, and pathway visibility.

Built to scale

An adaptable platform architecture engineered to support high-throughput processing, scalable sample volumes, and expanding project pipelines.

Research use only
No clinical, diagnostic, or treatment claims. All services positioned for discovery-stage and preclinical research within research-use-only frameworks.

Complex-matrix readiness

Built to support analytical work across plasma, serum, tissues, cell lysates, and other matrices that require more careful extraction and control strategies.

Flexible study support

Suitable for focused quantification needs as well as broader projects involving metabolism, degradation, interaction risk, or multi-analyte expansion.

Method-focused execution

Workflows are developed around analytical fit, compound behavior, and study purpose to improve clarity from planning through data delivery.

Service Architecture

Service architecture built around the right analytical starting point.

Our DMPK bioanalytical services are organized around the analytical questions researchers most often need to solve—from targeted quantification and stability assessment to metabolism studies, DDI support, multi-analyte strategies, difficult matrices, and method development. This structure helps visitors identify the most relevant scientific starting point for their compounds, samples, and study goals.

01

Single Drug Quantification

A clear entry point for routine and advanced quantification workflows covering plasma, serum, tissue homogenates, cell lysates, and metabolite-focused measurement scenarios.

Plasma, tissue, cell, and metabolite routes →
02

Stability & Degradation Studies

Best positioned for compounds that require stronger discussion around bench-top stability, freeze-thaw handling, autosampler behavior, stress conditions, or degradation-product visibility.

Forced degradation and stability-indicating design →
03

Drug Metabolism & Biotransformation

Dedicated space for pathway mapping, soft-spot logic, metabolite profiling, and biotransformation narratives that do not fit comfortably under simple concentration reporting.

MetID and pathway-focused support →
04

Drug–Drug Interaction (DDI) Support

Structured for DDI-driven projects where co-administered analytes, metabolic pathways, or interaction liabilities shape assay design and reporting expectations.

Interaction-aware assay support →
05

Multi-Analyte Panel Development

Useful when the homepage needs to communicate multiplex efficiency, broader assay economy, and panel logic for related compounds, metabolites, or pathway members.

Multiplex and panel development →
06

Challenging Compounds & Matrices

A high-value block for low-recovery samples, lipid-rich tissues, sticky analytes, low-volume inputs, difficult lysis buffers, and matrix-effect-prone workflows.

Complex samples and difficult chemistry →
07

Method Development & Validation

Important as a standalone route because many visitors are not buying analysis only—they are buying analytical confidence, fit-for-purpose design, and validation logic.

Method strategy, qualification, and validation →
Oncology Drugs
Cardiovascular Drugs
Anti-Infective Drugs
CNS Drugs
Endocrine & Metabolic
Immunosuppressive
Gastrointestinal
Analgesics & Controlled
Natural Products
At a Glance

Scientific bioanalysis for complex DMPK research.

Modern DMPK studies often involve more than routine quantification alone. Compound behavior, sample complexity, metabolic pathways, degradation risk, and method suitability can all shape the quality and usefulness of the final data. Our bioanalytical services are built to address these challenges through a more disciplined and study-aware scientific approach.

Built for demanding bioanalytical questions

Our DMPK platform supports research teams working with complex compounds, difficult matrices, metabolism-related workflows, and method-sensitive analytical objectives. The emphasis is not only on generating data, but on applying the right analytical logic to the study at hand.

  • Quantitative workflows across diverse sample types
  • Support for metabolism, stability, and transformation-related studies
  • Method strategies shaped by matrix complexity and compound behavior
  • Quality-conscious execution under ISO 17025-accredited practice
Core strength A DMPK bioanalytical service platform combining technical depth, matrix awareness, and structured laboratory execution for complex research programs.
Project Workflow

A structured workflow for reliable DMPK bioanalysis.

Our projects follow a stepwise analytical workflow designed to align study goals, compound behavior, matrix complexity, and method strategy. Each stage is structured to support clear decision-making and consistent execution from planning through data delivery.

📋
1

Project Scoping

Define analytes, matrices, expected concentration ranges, sample availability, and the scientific questions the study is intended to address.

🔍
2

Feasibility Assessment

Evaluate sample complexity, extraction behavior, sensitivity requirements, and whether direct quantification or a broader method strategy is more appropriate.

⚗️
3

Method Development

Establish chromatographic conditions, ion transitions, internal standard strategy, and matrix handling approaches, with attention to stability and analytical robustness.

📊
4

Sample Analysis

Perform quantitative analysis with structured QC design, batch control logic, and matrix-aware verification to ensure consistent analytical performance.

📁
5

Data Delivery

Provide organized datasets, concentration summaries, and reporting outputs aligned with the study design and analytical objectives.

Coverage Architecture

Bioanalytical support across diverse drug classes.

Our DMPK bioanalytical services support a wide range of compound types commonly encountered in discovery and preclinical research. Different drug classes often present distinct analytical challenges, and our workflows are designed to adapt to variations in structure, metabolism, matrix behavior, and method requirements.

Anti-Infective Drugs

Useful for concentration workflows, stability-sensitive compounds, and metabolism or interaction narratives tied to anti-infective development programs.

Oncology Drugs

Supports complex exposure questions, metabolite visibility, tissue-oriented workflows, and analytical designs that fit oncology discovery pipelines.

Cardiovascular Drugs

Fits programs that need scalable quantification, panel logic, or clean route-building for established and emerging cardiovascular analytes.

CNS Drugs

Especially valuable for difficult matrices, tissue distribution narratives, and analytes where low abundance or matrix interference must be addressed carefully.

Analgesics & Controlled Drugs

Provides room for targeted quantification, stability-aware handling, and expanded assay pages for compounds with tighter analytical handling needs.

Endocrine & Metabolic Drugs

Strong fit for pathway-driven projects, metabolite tracking, and category expansion into panels, endogenous overlap, or structurally related analyte sets.

Immunosuppressive Drugs

Supports pages that require careful discussion of bioanalysis, co-administered compound context, and broader DDI or metabolism-oriented workflows.

Gastrointestinal & Hepatobiliary Drugs

Useful for route-specific metabolism stories, liver-related sample logic, and compound classes where degradation or biotransformation messaging matters.

Natural Products

A good anchor for difficult chemistry, low-abundance analytes, structurally diverse compounds, and methods that require stronger customization language.

Resource Direction

Technical resources to support DMPK research decisions.

Beyond analytical services, we provide supporting content to help research teams better understand method selection, matrix challenges, compound behavior, and study planning considerations commonly encountered in DMPK bioanalysis.

Laboratory environment

A dedicated image area for your laboratory photograph, positioned to reinforce technical credibility, controlled workflows, and ISO 17025-aligned execution.

A focused DMPK bioanalysis platform

As part of the Creative Proteomics portfolio, this platform is dedicated to DMPK bioanalysis, with an emphasis on quantitative workflows, metabolism-related studies, and matrix-aware analytical strategies for discovery and preclinical research.

Creative Proteomics expertiseBacked by established experience in mass spectrometry–based analysis and bioanalytical workflows.
Dedicated DMPK focusA service structure centered specifically on DMPK-related analytical needs rather than general analytical offerings.
ISO 17025 laboratory qualityAccredited laboratory practices supporting reliable, controlled, and consistent analytical execution.
Trusted Collaborators

Great Minds Choose Creative Proteomics

We are proud to partner with leading pharmaceutical, biotech, and academic institutions worldwide to advance DMPK research.

Homepage FAQ

Frequently asked questions about DMPK bioanalysis

Below are common questions related to DMPK bioanalytical services, study planning, and analytical workflows in discovery and preclinical research.

What types of samples can be analyzed in DMPK bioanalysis?+
Common sample types include plasma, serum, tissues, and cell lysates. Depending on the study design, other matrices may also be supported, especially when additional preparation or matrix-specific method adjustments are required.
Do you support both single-analyte and multi-analyte quantification?+
Yes. Workflows can be designed for single-drug quantification or expanded to multi-analyte panels, depending on the analytical goals and study requirements.
How do you handle complex matrices such as tissues or cell lysates?+
Complex matrices are addressed through matrix-aware method strategies, including optimized extraction approaches, recovery evaluation, and control of matrix effects to support reliable quantification.
Can your services support drug metabolism or biotransformation studies?+
Yes. Analytical workflows can be adapted to support metabolism-related studies, including metabolite monitoring and compound transformation–related analytical questions.
Do you provide support for stability and degradation studies?+
Yes. Stability considerations can be incorporated into method design and study workflows, including evaluation of degradation risk and handling strategies to maintain analytical integrity.
How are analytical methods developed and optimized?+
Method development typically involves optimization of chromatographic conditions, ion transitions, internal standards, and matrix handling approaches to align with the specific analytical objective.
What level of sensitivity can be achieved in LC-MS/MS analysis?+
Sensitivity depends on compound properties, matrix type, and method design. Analytical strategies are adjusted to meet study-specific requirements while maintaining selectivity and robustness.
Do you support drug–drug interaction (DDI) related analytical workflows?+
Yes. DDI-related studies can be supported through targeted analytical approaches designed to assess interaction-related changes in compound behavior or concentration profiles.
What kind of data reporting is provided?+
Data outputs typically include structured datasets, concentration summaries, and supporting analytical information aligned with the study design and reporting needs.
Are your services suitable for discovery and preclinical research only?+
Yes. All services are positioned within research-use-only frameworks and are intended to support discovery-stage and preclinical studies.
How do you ensure data reliability and consistency?+
Analytical workflows follow structured QC strategies, method-focused execution, and ISO 17025-accredited laboratory practices to support consistent and reliable results.
Can you work with challenging compounds or low-abundance analytes?+
Yes. Analytical strategies can be adapted to address compound-specific challenges, including low concentration levels, instability, or difficult extraction behavior.
inquiry
Online Inquiry
Quick Links

Home

Service

Library

Resource

About Us

Contact Us

USA

Tel:

Fax:

Email:

Germany

Copyright © 2026 Creative Proteomics. All rights reserved.